2026-01-02 - Analysis Report
Okay, here's a comprehensive analysis of Intuitive Surgical (ISRG) based on the data you provided.

**1) Return Rate Comparison:**

*   **Company Overview:** Intuitive Surgical Inc. designs, manufactures, and markets the da Vinci surgical system and related instruments and accessories.
*   **ISRG Cumulative Return:** 80.65%
*   **VOO (S&P 500) Cumulative Return:** 105.07%
*   **Divergence:** -24.42 (Relative Divergence: 29.2)

**Analysis:** ISRG has underperformed the S&P 500 over the observed period, with a cumulative return that is roughly 24.42% lower.  The relative divergence of 29.2 indicates that the current divergence is relatively closer to the minimum divergence historically compared to the maximum divergence historically.

**Alpha, Beta Analysis:**

| Year       | CAGR     | MDD   | Alpha   | Beta | Cap(B) |
|------------|----------|-------|---------|------|--------|
| 2016-2018  | 166.0%  | 72.0% | 136.0% | 1.2  | 57.2   |
| 2017-2019  | 156.0%  | 72.0% | 114.0% | 1.4  | 70.6   |
| 2018-2020  | 90.0%   | 81.1% | 57.0%  | 1.2  | 97.8   |
| 2019-2021  | 106.0%  | 81.1% | 30.0%  | 1.2  | 128.8  |
| 2020-2022  | 42.0%   | 84.4% | 23.0%  | 1.2  | 95.1   |
| 2021-2023  | 35.0%   | 85.6% | 7.0%   | 1.4  | 120.9  |
| 2022-2024  | 84.0%   | 82.0% | 53.0%  | 1.3  | 187.1  |
| 2023-2025  | 131.0%  | 75.9% | 63.0%  | 1.2  | 203.0  |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate has been strong but volatile, ranging from 35% to 166%.  Recent years (2020-2025) show significant declines compared to earlier periods (2016-2019).
*   **MDD:** The Maximum Drawdown is consistently high, indicating significant risk. Drawdowns range from 72% to 85.6%.
*   **Alpha:** Alpha, representing excess return above the benchmark, has also declined significantly in recent periods.  This reinforces the underperformance relative to the S&P 500.
*   **Beta:** Beta hovers around 1.2-1.4, suggesting ISRG's price is more volatile than the market.
*   **Cap:** Market capitalization increased steadily over the periods.

**2) Recent Stock Price Fluctuations:**

*   **Current Price:** 566.36
*   **Previous Close:** 572.63
*   **Change:** -1.09
*   **5-day SMA:** 573.87
*   **20-day SMA:** 565.807
*   **60-day SMA:** 538.1482

**Analysis:** The current price is below the 5-day SMA but above the 20-day SMA, implying that the stock may be facing short term volatility. The 20-day SMA is above the 60-day SMA, indicating an upward trend in the recent price movement.

**3) RSI, PPO, and Divergence Analysis:**

*   **MRI (Market Risk Indicator):** 0.9 (Medium Investment)
*   **RSI (Relative Strength Index):** 56.89
*   **PPO (Percentage Price Oscillator):** -0.11
*   **Hybrid Signal:** Buy 90% of cash (1 shares - Safe - MRI:0.80) (Cash Ratio: 0% on 2025-12-23)
*   **Recent (20 days) relative divergence change:** -1.3 (short-term decline)
*   **Expected Return (%):** 0.0%

**Analysis:**

*   The MRI suggests medium investment recommendation, which is reasonable.
*   The RSI is slightly above 50, indicating slightly bullish (but not overbought) momentum.
*   The negative PPO indicates that the short-term moving average is below the long-term moving average, suggesting a potential downtrend.
*   The hybrid signal recommends a high allocation of cash towards ISRG (90%), reflecting a relatively conservative stance.
*   The negative divergence change (-1.3) reinforces the short-term downward trend.
*   The 0% expected return, in comparison to the S&P 500, indicates low returns if invested long-term.

**4) Recent News & Significant Events:**

*   **Growth Guidance Update:** Quiver Quantitative highlights opinions on ISRG's 2025 growth guidance.
*   **Key Support Level:** Trefis suggests ISRG has hit a key support level, potentially signaling a buying opportunity.
*   **New Year's Day Slip:** ts2.tech notes ISRG slipped into 2026 as Wall Street closed for New Year's Day.
*   **Institutional Investment:** MarketBeat reports Roberts Wealth Advisors LLC has taken a position in ISRG.
*   **5-Year Outlook:** The Motley Fool discusses where Intuitive Surgical might be in 5 years.
*   **Technical Indicators Focus:** Meyka analyzes ISRG's technical indicators.

**Analysis:** Recent news coverage is mixed. Some articles suggest a buying opportunity (key support level), while others discuss growth guidance and technical indicators. The Motley Fool article on the 5-year outlook could provide valuable insights into the company's long-term potential.

**4-2) Analyst Opinions:**

*   **Consensus:** Buy
*   **Mean Recommendation:** 2.06 (~Buy)
*   **Number of Opinions:** 29
*   **Target Price:** Average: 599.60 / High: 700.00 / Low: 378.00

**Analysis:**  The analyst consensus is generally positive, with a "Buy" recommendation and a mean rating around 2. The average target price of 599.60 suggests potential upside from the current price of 566.36, but the wide range between high and low targets reflects uncertainty among analysts.

**5) Recent Earnings Analysis:**

| Date       | EPS  | Revenue      |
|------------|------|--------------|
| 2025-10-22 | 1.98 | 2.51 B$      |
| 2025-07-23 | 1.84 | 2.44 B$      |
| 2025-04-23 | 1.95 | 2.25 B$      |
| 2024-10-18 | 1.59 | 2.04 B$      |
| 2025-10-22 | 1.59 | 2.04 B$      |

**Analysis:** Earnings per share and revenue have generally increased over the past several quarters. The most recent quarter (2025-10-22) showed the highest EPS and revenue in the provided data.  The data seems to have a duplication on the 2025-10-22 and 2024-10-18 numbers.

**6) Financial Information:**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-09-30   | $2.51B    | 66.36%        |
| 2025-06-30   | $2.44B    | 66.31%        |
| 2025-03-31   | $2.25B    | 64.69%        |
| 2024-12-31   | $2.41B    | 68.04%        |
| 2024-09-30   | $2.04B    | 67.41%        |

**Analysis:** Revenue has been steadily increasing. The profit margins are consistently high, indicating strong profitability.

**Capital and Profitability:**

| Quarter      | Equity    | ROE      |
|--------------|-----------|----------|
| 2025-09-30   | $16.93B   | 4.16%    |
| 2025-06-30   | $17.85B   | 3.69%    |
| 2025-03-31   | $17.11B   | 4.08%    |
| 2024-12-31   | $16.43B   | 4.17%    |
| 2024-09-30   | $15.58B   | 3.63%    |

**Analysis:** Equity has increased, and the Return on Equity (ROE) has remained relatively stable.

**7) Comprehensive Analysis:**

Intuitive Surgical (ISRG) is a company with strong financials, including increasing revenue, high profit margins, and a healthy ROE.  However, the stock has underperformed the S&P 500 recently, as reflected in the negative divergence and declining Alpha values in recent years.  The high MDD values indicate significant risk.  The recent news is mixed, with some articles suggesting buying opportunities while others focus on growth guidance and technical indicators. Analyst opinions are generally positive, but with a wide range of target prices. Technical indicators present a mixed picture. The MRI suggests medium investment risk, the RSI is slightly bullish, and the PPO indicates a potential downtrend.  In summary, ISRG appears to be a fundamentally strong company with good growth potential, but it currently faces short-term headwinds and increased market volatility, contributing to recent underperformance and an expected return of 0% compared to the S&P 500. The hybrid signal suggests a conservative approach, recommending a high cash allocation towards the stock.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.